Atlas Trials

Cyclophosphamide and Docetaxel Every 3 Weeks as Neoadjuvant Therapy in Locally Advanced Breast Cancer

Clinical trial NCT01229605 · WITHDRAWN

Trial details

NCT number
NCT01229605
Sponsor
Tufts Medical Center
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2010-10-01
Primary completion
2011-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.